Gene Flow and Individual Relatedness Suggest Population Spatial Connectivity of Sinogastromyzon sichangensis (Cypriniformes: Balitoridae) in the Chishui River, China

stjosephs-hospital

 

  • Sinogastromyzon sichangensisis a hillstream loach endemic to the upper Yangtze River, China. It is unclear whether this fish lives in a very restricted area or may be dispersed over a long distance. In the present study spatial connectivity of populations of  sichangensis was investigated based on 343 individuals collected from 12 sites of Chishui River and employing 22 microsatellite loci.
  • The results of genetic diversity analysis showed that observed heterozygosity (HO) and polymorphism information content (PIC) ranged from 0.5653 to 0.6999 and 0.8513 to 0.8819, respectively. Population structure analysis suggested that  sichangensishad an unclear genetic structure. AMOVA showed that 69.36% of genetic variation was attributed to differentiation within individuals and all the pairwise genetic differentiation indices (FST) were low (mean FST = 0.0344), indicating weak differentiation among these populations.
  • Estimation of gene flow showed frequent flow among populations, and contemporary levels (mean contemporary migration rate, mc= 0.0131) were approximately equal to historical levels (mean historical migration rate, mh = 0.0147).
  • Individual relatedness analysis revealed a high level of sibship within and among different populations. The frequent gene flow and widespread sibship were due to  sichangensislaying drifting eggs which travel for a long distance until hatching, after which the juveniles or adults migrate upstream. The results of unclear geographic structure and frequent exchange also indicate that it is necessary to decrease the negative impacts of anthropogenic activities on the connectivity of rivers to protect the migration routes of S. sichangensis.

 

Case Report: Identification of a Novel Variant (m.8909T>C) of Human Mitochondrial ATP6 Gene and Its Functional Consequences on Yeast ATP Synthase

 

With the advent of next generation sequencing, the list of mitochondrial DNA (mtDNA) mutations identified in patients rapidly and continuously expands. They are frequently found in a limited number of cases, sometimes a single individual (as with the case herein reported) and in heterogeneous genetic backgrounds (heteroplasmy), which makes it difficult to conclude about their pathogenicity and functional consequences.

As an organism amenable to mitochondrial DNA manipulation, able to survive by fermentation to loss-of-function mtDNA mutations, and where heteroplasmy is unstable, Saccharomyces cerevisiae is an excellent model for investigating novel human mtDNA variants, in isolation and in a controlled genetic context. We herein report the identification of a novel variant in mitochondrial ATP6 gene, m.8909T>C. It was found in combination with the well-known pathogenic m.3243A>G mutation in mt-tRNALeu.

We show that an equivalent of the m.8909T>C mutation compromises yeast adenosine tri-phosphate (ATP) synthase assembly/stability and reduces the rate of mitochondrial ATP synthesis by 20-30% compared to wild type yeast. Other previously reported ATP6 mutations with a well-established pathogenicity (like m.8993T>C and m.9176T>C) were shown to have similar effects on yeast ATP synthase. It can be inferred that alone the m.8909T>C variant has the potential to compromise human health.

Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer

 

  • Endometrial cancer (EC) is the commonest gynaecological malignancy. Current prognostic markers are inadequate to accurately predict patient survival, necessitating novel prognostic markers, to improve treatment strategies. Telomerase has a unique role within the endometrium, whilst aberrant telomerase activity is a hallmark of many cancers.
  • The aim of the current in silico study is to investigate the role of telomere and telomerase associated genes and proteins (TTAGPs) in EC to identify potential prognostic markers and therapeutic targets. Analysis of RNA-seq data from The Cancer Genome Atlas identified differentially expressed genes (DEGs) in EC (568 TTAGPs out of 3467) and ascertained DEGs associated with histological subtypes, higher grade endometrioid tumours and late stage EC.
  • Functional analysis demonstrated that DEGs were predominantly involved in cell cycle regulation, while the survival analysis identified 69 DEGs associated with prognosis. The protein-protein interaction network constructed facilitated the identification of hub genes, enriched transcription factor binding sites and drugs that may target the network.
  • Thus, our in silico methods distinguished many critical genes associated with telomere maintenance that were previously unknown to contribute to EC carcinogenesis and prognosis, including NOP56WFS1ANAPC4and TUBB4A. Probing the prognostic and therapeutic utility of these novel TTAGP markers will form an exciting basis for future research.
stjosephs-hospital

stjosephs-hospital

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

 

Cancer immunotherapy has been emerged as a promising strategy for treatment of a broad spectrum of malignancies ranging from hematological to solid tumors. One of the principal approaches of cancer immunotherapy is transfer of natural or engineered tumor-specific T-cells into patients,

a so called “adoptive cell transfer”, or ACT, process. Construction of allogeneic T-cells is dependent on the employment of a gene-editing tool to modify donor-extracted T-cells and prepare them to specifically act against tumor cells with enhanced function and durability and least side-effects. In this context, CRISPR technology can be used to produce universal T-cells, equipped with recombinant T cell receptor (TCR) or chimeric antigen receptor (CAR), through multiplex genome engineering using Cas nucleases.

The robust potential of CRISPR-Cas in preparing the building blocks of ACT immunotherapy has broaden the application of such therapies and some of them have gotten FDA approvals. Here, we have collected the last investigations in the field of immuno-oncology conducted in partnership with CRISPR technology. In addition, studies that have addressed the challenges in the path of CRISPR-mediated cancer immunotherapy, as well as pre-treatment applications of CRISPR-Cas have been mentioned in detail.

Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways

 

Background: Although the advances in diagnostic and treatment strategies, lung cancer remains the leading cause of cancer-related deaths, worldwide, with survival rates as low as 16% in developed countries. Low survival rates are mainly due to late diagnosis and the lack of effective treatment. Therefore, the identification of novel, clinically useful biomarkers is still needed for patients with advanced disease stage and poor survival.

Micro(mi)RNAs are non-coding RNAs and potent regulators of gene expression with a possible role as diagnostic, prognostic and predictive biomarkers in cancer.

Methods: We applied global miRNA expression profiling analysis using TaqMan® arrays in paired tumor and normal lung tissues (n = 38) from treatment-naïve patients with lung adenocarcinoma (AD; n = 23) and lung squamous cell carcinoma (SCC; n = 15). miRNA target genes were validated using The Cancer Genome Atlas (TCGA) lung AD (n = 561) and lung SCC (n = 523) RNA-Seq datasets.

Results: We identified 33 significantly deregulated miRNAs (fold change, FC ≥ 2.0 and p < 0.05) in tumors relative to normal lung tissues, regardless of tumor histology. Enrichment analysis confirmed that genes targeted by the 33 miRNAs are aberrantly expressed in lung AD and SCC, and modulate known pathways in lung cancer. Additionally, high expression of miR-25-3p was significantly associated (p < 0.05) with poor patient survival, when considering both tumor histologies.

Conclusions: miR-25-3p may be a potential prognostic biomarker in non-small cell lung cancer. Genes targeted by miRNAs regulate EGFR and TGFβ signaling, among other known pathways relevant to lung tumorigenesis.

 

FOS-B Human Recombinant

rAP-4393 Inquiry Ask for price

FOS-B Human Recombinant Protein

PROTP53539 Regular: 5ug
EUR 574.8
Description: FOS-B Human Recombinant (a.a. 113-151) expressed in E.coli, shows a 32 kDa SDS-PAGE (Including GST).;The FOS-B is purified by proprietary chromatographic techniques.

Fos B

GWB-69F0E1 0.01 mg Ask for price

Recombinant (E.Coli, GST) Human FOS-B

RP-945 2 ug
EUR 416.4

FOS B antibody

29246 100ul
EUR 319

FOS B antibody

29246-100ul 100ul
EUR 302.4

Fos B Rabbit pAb

E2381043 100ul
EUR 225
Description: Available in various conjugation types.

Fos B Rabbit mAb

58812 100ul
EUR 339

Fos B Rabbit mAb

A24339 200μL
EUR 323.7
Description: A synthetic peptide corresponding to a sequence within amino acids 371-470 of human Desmin (P17661).

Fos B Rabbit mAb

E2R381043 100ul
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Human Proto- oncogene c- Fos, FOS ELISA KIT

ELI-04266h 96 Tests
EUR 988.8

Recombinant Human FOS-B Protein, Untagged, E.coli-2ug

QP11898-2ug 2ug
EUR 294

Recombinant Human FOS-B Protein, Untagged, E.coli-5ug

QP11898-5ug 5ug
EUR 403.2

Fos B Polyclonal Antibody

E20-71738 100ug
EUR 225
Description: Available in various conjugation types.

FOS B Conjugated Antibody

C29246 100ul
EUR 476.4

Fos B Polyclonal Antibody

ABP51360-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody

ABP51360-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody

ABP51360-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody

E44H02228 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Recombinant Human FOS-B Protein, Untagged, E.coli-10ug

QP11898-10ug 10ug
EUR 663.6

FOS ELISA KIT|Human

EF005100 96 Tests
EUR 826.8

Human FOS ELISA Kit

ELA-E1291h 96 Tests
EUR 988.8

Human FOS ELISA Kit

EHF0120 96Tests
EUR 625.2

Human FOS ELISA Kit

IHUFOSKT each
EUR 548
Description: Human FOS ELISA Kit

Human Proto-Oncogene C-Fos (FOS) CLIA Kit

20-abx492601
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human FOS/ Proto-oncogene c-Fos ELISA Kit

E0936Hu 1 Kit
EUR 515
Description: G0S7,Cellular oncogene fos,G0/G1 switch regulatory protein 7

Human FOS(Proto-oncogene c-Fos) ELISA Kit

EKF58552-48T 48T
EUR 396.9

Human FOS(Proto-oncogene c-Fos) ELISA Kit

EKF58552-5x96T 5x96T
EUR 2693.25

Human FOS(Proto-oncogene c-Fos) ELISA Kit

EKF58552-96T 96T
EUR 567

Human FOS(Proto-oncogene c-Fos) ELISA Kit

EH1465 96T
EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml

Human Proto-oncogene c-Fos (FOS) ELISA Kit

abx570165-96tests 96 tests
EUR 801.6

Human Proto-Oncogene C-Fos (FOS) ELISA Kit

20-abx151580
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Proto-oncogene c-Fos (FOS) ELISA Kit

RK07956 96T
EUR 280

Human FOS / Proto-oncogene c-Fos ELISA Kit

E1291h 96T
EUR 736

Human FOS shRNA Plasmid

20-abx951644
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Anti-Fos B/FOSB Antibody

PA1478 100ug/vial
EUR 352.8

Anti-Fos B/FOSB Antibody

RP1086 100ug/vial
EUR 400.8

OPPA01398-2UG - FOS-B Protein

OPPA01398-2UG 2ug
EUR 324

Fos B Rabbit Polyclonal Antibody

ES2359-100ul 100ul
EUR 124
Description: A Rabbit Polyclonal antibody against Fos B from Human/Mouse/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B Rabbit Polyclonal Antibody

ES2359-50ul 50ul
EUR 74
Description: A Rabbit Polyclonal antibody against Fos B from Human/Mouse/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Human FBJ Murine Osteosarcoma Viral OncoGene Homolog B, FOS-B GENLISA ELISA

KBH4679 1 x 96 wells
EUR 286

Fos B (FOSB) goat polyclonal antibody

GT15126-100 100 µg Ask for price

FOS Recombinant Protein (Human)

RP012430 100 ug Ask for price

FOS (untagged)-Human FBJ murine osteosarcoma viral oncogene homolog (FOS)

SC116873 10 µg Ask for price

Human c Fos ELISA kit

E01A2365 96T
EUR 700
Description: ELISA

Human c Fos ELISA kit

E01C0735-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human c Fos ELISA kit

E01C0735-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human c Fos ELISA kit

E01C0735-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

FOS ORF Vector (Human) (pORF)

ORF004144 1.0 ug DNA
EUR 114

Human FOS knockout cell line

ABC-KH5650 1 vial Ask for price
Description: Human FOS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human FOS knockdown cell line

ABC-KD5650 1 vial Ask for price
Description: Human FOS knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human FOS Protein Lysate 20ug

IHUFOSPLLY20UG each
EUR 213
Description: Human FOS Protein Lysate 20ug

FOS ELISA Kit (Human) (OKCD07290)

OKCD07290 96 Wells
EUR 1123.2
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.054ng/mL

FOS ELISA Kit (Human) (OKEH04574)

OKEH04574 96 Wells
EUR 1216.8
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.12 ng/mL

FOS ELISA Kit (Human) (OKDD00273)

OKDD00273 96 Wells
EUR 1107.6
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ;Assay info: Quantitative Sandwich ELISA;Sensitivity: < 0.064 ng/mL

Human Fos-related antigen 2 (FOSL2)

1-CSB-EP008793HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Fos-related antigen 2(FOSL2) expressed in E.coli

FOS (GFP-tagged) - Human FBJ murine osteosarcoma viral oncogene homolog (FOS)

RG202597 10 µg Ask for price

Fos B (phospho Ser27) Polyclonal Antibody

13857 100ul
EUR 319

Fos B (phospho Ser27) Polyclonal Antibody

E013857 100μg/100μl
EUR 255
Description: Available in various conjugation types.

Fos B (phospho Ser27) Polyclonal Antibody

E20-61178 100ug
EUR 225
Description: Available in various conjugation types.

Fos B (phospho Ser27) Polyclonal Antibody

ABP54356-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody

ABP54356-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody

ABP54356-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody

E44H00397 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

FOS

CSB-CL008790HU 10 μg plasmid + 200μl Glycerol Ask for price

FOS (Myc-DDK-tagged)-Human FBJ murine osteosarcoma viral oncogene homolog (FOS)

RC202597 10 µg Ask for price

Human FOS Like Antigen 1 (FOSL1) Protein

20-abx066690
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human FOS Like Antigen 1 (FOSL1) Protein

abx066690-100g 100 µg
EUR 612.5

Human FOS Like Antigen 1 (FOSL1) Protein

abx066690-10g 10 µg
EUR 237.5

Human FOS Like Antigen 1 (FOSL1) Protein

abx066690-50g 50 µg
EUR 425

Human FOS Like Antigen 2 (FOSL2) Protein

abx680375-50g 50 µg
EUR 225

OKCD07290-96W - FOS ELISA Kit (Human)

OKCD07290-96W 96Wells
EUR 750

OKEH04574-96W - FOS ELISA Kit (Human)

OKEH04574-96W 96Wells
EUR 550

Fos B (FOSB) (1-338)) mouse polyclonal antibody

MO15054-100 100 µg Ask for price

OOCA00667-25T - Human FOS Primer Pair

OOCA00667-25T 25Tests
EUR 229

FOS sgRNA CRISPR Lentivector set (Human)

K0794201 3 x 1.0 ug
EUR 406.8

Recombinant Human Fos-related antigen 2 (FOSL2)

CSB-EP008793HU 1197 mg Ask for price

Recombinant Human Fos-related antigen 2(FOSL2)

AP70312 1mg
EUR 1978

Anti-Fos B/FOSB Antibody Picoband™

A01569-1 10ug
EUR 154
Description: Immunohistochemistry (Paraffin-embedded Section), 2-5μg/ml, Human;_x000D_Immunocytochemistry/Immunofluorescence, 5μg/ml, Human;_x000D_Direct ELISA, 0.1-0.5μg/ml, Human

FOS-Like Antigen 2 Human Recombinant

rAP-4262 Inquiry Ask for price

Human V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) Protein

20-abx166659
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) Protein

abx166659-100g 100 µg
EUR 550

Human V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) Protein

abx166659-10g 10 µg
EUR 212.5

Human V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) Protein

abx166659-50g 50 µg
EUR 387.5

FOSL2 (untagged)-Human FOS-like antigen 2 (FOSL2)

SC110898 10 µg Ask for price

FOSL1 (untagged)-Human FOS-like antigen 1 (FOSL1)

SC125319 10 µg Ask for price

anti-Fos B

YF-PA11841 50 ul
EUR 435.6
Description: Mouse polyclonal to Fos B

anti-Fos B

YF-PA11842 50 ug
EUR 435.6
Description: Mouse polyclonal to Fos B

anti-Fos B

YF-PA11843 100 ul
EUR 483.6
Description: Rabbit polyclonal to Fos B

anti-Fos B

YF-PA11844 100 ug
EUR 483.6
Description: Rabbit polyclonal to Fos B
Steven Washington

Related Post

stjosephs-hospital

A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaA Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Background: Induction chemotherapy (IC) adopted by concurrent chemoradiotherapy is the mainstay therapy for sufferers with locoregionally superior nasopharyngeal carcinoma. Nonetheless, some sufferers acquire little profit and expertise pointless poisonousities from IC.